Drugs / Polio Sabin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05155579 | May 2022 → May 2025 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01262872 | Feb 2011 → Mar 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Also used as a comparator or background therapy in 9 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02961595 Comparator | Oct 1999 → Nov 2016 | enterovirus infectious disease, prediabetes syndrome, type 1 diabetes mellitus | Tampere University | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01098474 Background | Jul 2010 → Apr 2011 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00436007 Background | Apr 2007 → Sep 2008 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00263666 Background | Mar 2005 → Feb 2008 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT01345240 Background | Nov 2011 → Jan 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01175083 Background | Jun 2011 → Jan 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00678301 Background | Jun 2008 → Nov 2009 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00547248 Background | Oct 2007 → May 2008 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00344318 Background | Aug 2006 → Apr 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polio Sabin | “Sixty-four children (34 males) were given doses of OPV (Polio Sabin®, SB Biologicals, Rixensart, Belgium) at the age of 2, 3, 6 and 12 months during the years 1999-2000 (two...” NCT02961595 ↗ |
| Known as | Oral Polio Vaccine (OPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05155579 ↗ |
| Modality | Vaccine | “Tritanrix HepB Hib and Polio Sabin vaccines” NCT00263666 ↗ |
| Route | Oral | “Polio Sabin™ was administered orally.” NCT00436007 ↗ |